from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3041c/-

LFCtreatmentdescriptionclass of inhibitor

-1.227

Amikacinug/mL Amikacintranslation

-0.701

Cap5-10ug/mL Capreomycintranslation

-0.613

Rox10-50 ug/mL Roxithromycintranslation

-0.490

SM2-5 ug/mL Streptomycintranslation

-0.279

Tet5-10 ug/mL Tetracyclinetranslation

-1.681

Rif0.2-5ug/mL Rifampicintranscription

-0.634

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.149

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.768

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.155

CPZ10-50 ug/mL Chlorpromazinerespiration

0.409

Clofazimine10-13 ug/mL Clofaziminerespiration

0.457

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.259

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.374

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.555

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.645

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.390

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.179

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.096

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.668

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.809

KCN5-20 ug/mL Potassium cyaniderespiration

-0.088

NaN30.2-2 mM Sodium aziderespiration

0.613

Nigericin50 uM Nigericinrespiration

0.674

TRC10-150 ug/mL Triclosanrespiration

-1.147

TRZ10-25 ug/mL Thioridazinerespiration

0.101

Valinomycin0.5-10 uM Valinomycinrespiration

0.305

ZnSO42 mM ZnSO4respiration

2.191

menadione6-10 ug/mL Menadionerespiration

0.287

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.042

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.352

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.187

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.412

NRP_1Non-replicating persistence stage 1dosRassociated

0.186

Amp0.2mg/mL AmpicillincellWall

0.174

Cephalexin20-100 ug/mL CephalexincellWall

0.262

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.214

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.195

EMB10-20 ug/mL EthambutolcellWall

0.227

Eta12-40 ug/mL EthionamidecellWall

0.232

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.008

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.937

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.308

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.476

BZA0.12 mg/mL BenzamidearomaticAmides

-0.075

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.580

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.504

H2O24 mM hydrogen peroxideDNAdamaging

0.141

Levo10 ug/mL LevofloxacinDNAdamaging

-0.733

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.658

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.323

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.928

UVUV-irradiationDNAdamaging

2.999

ARP41-4 ug/mL Antitubercular compound ARP4?

0.869

Antimycin12.5-50 ug/mL Antimycin A?

0.645

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.903

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.795

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.271

PA8240.2-2 ug/mL PA-824?

-0.886

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.149

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.153

Verapamil50 uM Verapamil?

0.833

mercaptoethanol2 mM 2-Mercaptoethanol?

1.137

methoxatin10-20 ug/mL Methoxatin?